Clinical Bioequivalence Study on Two Gliclazide 80mg Tablet Formulations

NCT02643329 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
17
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Bright Future Pharmaceuticals Factory O/B Bright Future Pharmaceutical Laboratories Limited

Collaborators